Evaluation of Elevated RBC Count, Hemoglobin, Hematocrit, MCV, and MCH
Primary Recommendation
The combination of elevated RBC count, hemoglobin, hematocrit WITH elevated MCV and MCH most strongly suggests either polycythemia vera (PV) or hemochromatosis, and you should immediately test JAK2 mutation status and serum ferritin/transferrin saturation to differentiate between these two diagnoses. 1, 2
Diagnostic Approach
Step 1: Confirm True Polycythemia
- Verify hemoglobin >16.5 g/dL in men or >16.0 g/dL in women, or hematocrit >49% in men or >48% in women as major criterion for PV 1
- The elevated MCV and MCH distinguish this from typical secondary polycythemia, which usually presents with normal or low MCV 3, 4
Step 2: Order Initial Discriminating Tests
For Polycythemia Vera:
- JAK2 V617F mutation testing (exon 14) is the critical first test - present in >97% of PV cases and serves as a major diagnostic criterion 1
- If JAK2 V617F negative, test for JAK2 exon 12 mutations 1
- Serum erythropoietin level - will be low (below reference range) in PV 1
- Bone marrow biopsy showing hypercellularity with trilineage growth supports PV diagnosis 1
For Hemochromatosis:
- Transferrin saturation and serum ferritin - elevated in hemochromatosis 2, 5
- HFE gene testing for C282Y homozygosity - the most common genetic cause 2, 5
- The elevated MCV (mean 94.4-95.3 fL) and MCH are characteristic findings in C282Y homozygotes due to increased iron uptake and hemoglobin synthesis by erythroid cells 2, 5
Step 3: Apply Diagnostic Criteria
PV diagnosis requires:
- Both major criteria (elevated hemoglobin/hematocrit AND JAK2 mutation) PLUS at least one minor criterion, OR
- First major criterion plus two minor criteria 1
Minor criteria include:
- Bone marrow histology consistent with myeloproliferative disorder 1
- Serum erythropoietin below normal range 1
- Endogenous erythroid colony formation 1
Key Distinguishing Features
Hemochromatosis Pattern:
- MCV typically 94-95 fL (moderately elevated) 2, 5
- MCH and MCHC also elevated due to increased hemoglobin content per cell 5
- Transferrin saturation ≥75% strongly associated with higher MCV 5
- Erythrocytes appear larger with increased diameter and well-filled with hemoglobin on peripheral smear 5
- After iron depletion therapy, MCV/MCH/MCHC decrease but remain above normal 5
Polycythemia Vera Pattern:
- Can present with normal or elevated MCV 1, 6
- When iron deficiency coexists with PV, may see microcytic polycythemia (high RBC with low MCV) 3
- JAK2 mutation positive 1
- Low serum erythropoietin distinguishes from secondary causes 1
Critical Pitfalls to Avoid
- Do not assume thalassemia minor - while microcytic polycythemia suggests thalassemia, your patient has macrocytic indices 3
- Iron deficiency can mask PV - hemoglobin levels will be artificially lowered; formal PV diagnosis requires demonstrating criteria after iron replacement 1
- Do not rely on red cell mass measurement - this test is cumbersome, costly, and diagnostically suboptimal; use hemoglobin/hematocrit with molecular markers instead 6
- Secondary polycythemia with iron deficiency can present with elevated RBC but typically shows low MCV initially, which normalizes with iron replacement while RBC count remains elevated 3
Additional Considerations
The MCV-hematocrit relationship follows a dynamic equilibrium where larger RBCs accommodate more hemoglobin, directly impacting total hemoglobin levels 4. In your patient, the concordant elevation of all parameters (RBC, hemoglobin, hematocrit, MCV, MCH) suggests a primary process increasing both RBC production and individual cell hemoglobin content, making PV and hemochromatosis the leading diagnoses 2, 5, 4.